Business

MiniMed to Showcase MiniMed Flex™ and MiniMed Go™ at the American Diabetes Association Scientific Sessions

MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced an overview of its upcoming presence at the American Diabetes Association's (ADA) Scientific Sessions in New Orleans June 5-8. The meeting marks MiniMed's first U.S. diabetes congress since becoming a standalone public company — and the first to feature its newest generation of technology designed to give people with diabetes more freedom every day.

articleMinimed Group, Inc.May 27, 20266/company/minimed-group-inc/news/minimed-to-showcase-minimed-flextm-and-minimed-gotm-at-the-american-diabetes-association-scientific-sessions
MiniMed to Showcase MiniMed Flex™ and MiniMed Go™ at the American Diabetes Association Scientific Sessions

About this update from Minimed Group, Inc.

[{"type":"text","content":"Following this week's launch of MiniMed Go™, MiniMed will bring hands-on demonstrations of the system and new clinical data","length":132,"tagName":"p","attribs":{}},{"type":"text","content":"NORTHRIDGE, Calif., May 27, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced an overview of its upcoming presence at the American Diabetes Association's (ADA) Scientific Sessions in New Orleans June 5-8. The meeting marks MiniMed's first U.S. diabetes congress since becoming a standalone public company — and the first to feature its newest generation of technology designed to give people with diabetes more freedom every day.","length":493,"tagName":"p"},{"type":"image","alt":"MiniMed logo","displaySize":"","headline":null,"caption":"MiniMed logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":58,"url":"https://media.zenfs.com/en/prnewswire.com/a9194151363b7c5ea99a1a3531923d4d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ziglwX5lub0d3e01GQrLFg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTEwMg--/https://media.zenfs.com/en/prnewswire.com/a9194151363b7c5ea99a1a3531923d4d","width":400,"height":58},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/82ArrbZ3XYsfKp5aBzesOQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTkz/https://media.zenfs.com/en/prnewswire.com/a9194151363b7c5ea99a1a3531923d4d","width":400,"height":58}}},{"type":"text","content":"At ADA, MiniMed will showcase technology designed to reduce the daily burden of diabetes while delivering strong clinical outcomes. From advanced automation to smaller, more intuitive designs, the company continues to focus on one simple idea: to make every day a better day for people with diabetes.","length":300,"tagName":"p"},{"type":"text","content":"In addition to its latest innovations, MiniMed will present emerging clinical data demonstrating the real-world impact of its connected solutions, including the impact of its recently refreshed sensor portfolio.","length":211,"tagName":"p"},{"type":"text","content":"Attendees will also have hands-on opportunities to explore the highly anticipated MiniMed Flex™ system, a next-generation screenless, smartphone-controlled pump with real-time SmartGuard™ automation, and MiniMed Go™, the smart insulin pen system that remembers, reminds and reco...

More updates from Minimed Group, Inc.

American Diabetes AssociationMiniMedType 2 DiabetesMatias CastroMedical DirectorPrincipal Medical Science Liaison Specialistdiabetes technology